Provided by Tiger Trade Technology Pte. Ltd.

REMEGEN

77.100
+2.3003.07%
Volume:3.12M
Turnover:238.35M
Market Cap:43.45B
PE:51.17
High:77.500
Open:73.500
Low:73.500
Close:74.800
52wk High:126.600
52wk Low:63.300
Shares:563.61M
HK Float Shares:208.58M
Volume Ratio:1.32
T/O Rate:1.50%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.507
ROE:109.10%
ROA:39.01%
PB:4.47
PE(LYR):51.17
PS:4.65

Loading ...

Movement Alert|RemeGen Rises 6.93% in Regular Trading, Innovative Drug Payment Reform Catalyzes Biotech Sector Rally

Market Focus
·
Jul 03

Market Analysis: Meta's AI Compute Sale Not a Bearish Signal; Healthcare Stocks Surge on Multiple Catalysts

Stock News
·
Jul 02

Movement Alert|RemeGen Rises 7.34% in Regular Trading, Medical Insurance Negotiation List Published as Lock-Up Selling Restrictions Boost Sentiment

Market Focus
·
Jul 02

Movement Alert|RemeGen Falls 5.27% in Regular Trading, Massive Restricted Share Unlock Triggers Profit-Taking After Prior Session Surge

Market Focus
·
Jun 30

Hong Kong Market Rallies: Hang Seng Gains 1.57%, Biotech and Tech Sectors Lead Charge

Stock News
·
Jun 29

Hong Kong Market Midday Recap: Hang Seng Index Gains 2.12%, Reclaims 23,000 Level; Tech Index Up 3.68% with Broad-Based Gains

Deep News
·
Jun 29

Hong Kong Market Midday Update: Hang Seng Index Climbs 2.12%, Biotech and Pharma Stocks Surge

Stock News
·
Jun 29

Movement Alert|Remegen Rises 5.38% in Regular Trading, Lock-up Share Selling Restrictions and New Drug Approvals Drive Gains

Market Focus
·
Jun 29

Movement Alert|RemeGen Rises 5.31% in Regular Trading, HK Biotech Sector Extends Rebound as Lock-Up Share Selling Restrictions Ease Overhang Concerns

Market Focus
·
Jun 24

Movement Alert|RemeGen Rises 5.02% in Regular Trading, Sector Rebounds as Lock-up Expiry Selling Pressure Eased by Regulatory Restriction

Market Focus
·
Jun 23

Hong Kong Stocks Flat In Morning Trading

Dow Jones
·
Jun 23

HK Movers | Biotech Stocks Jump. InnoGen up over 17%; Alphamab, Hengrui Pharma, Laekna, Keymed Bio up Around 5%; Joinn, Remegen up About 4%

Tiger Newspress
·
Jun 23

Remegen to Release 193 Million Locked Shares on July 1

Stock News
·
Jun 22

Movement Alert|RemeGen Falls 5.33% in Regular Trading, HK Innovative Drug Sector Under Sustained Selling Pressure

Market Focus
·
Jun 22

RemeGen (SEHK:9995) Is Down 8.1% After Expanded Telitacicept Approvals in China Reshape Its Pipeline Narrative

Simply Wall St.
·
Jun 21

RemeGen (SEHK:9995) Stock Could Be 39% Below Fair Value After Telitacicept Approvals

Simply Wall St.
·
Jun 19

REMEGEN Announces Board Re-Elections, Including Chairman and CEO

Stock News
·
Jun 16

Movement Alert|RemeGen Falls 5.06% in Regular Trading, HK Innovative Drug Sector Under Sustained Selling Pressure

Market Focus
·
Jun 16

Innovative Drug Stocks See Broad Gains as Sector's Outbound Licensing Activity Remains Robust, Supported by Policy Tailwinds and Commercialization Progress

Stock News
·
Jun 12

Movement Alert|RemeGen Rises 5.38% in Regular Trading, Dual Indication Approval for Core Drug Telitacicept Continues to Boost Sentiment

Market Focus
·
Jun 12